NCT00107861 Interferon-Beta Gene Transfer (Ad.hIFN-β) as Treatment for Refractory Colorectal Carcinoma With Liver Metastases Status COMPLETED Phase PHASE1/PHASE2
NCT00106184 Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM) Status COMPLETED Phase PHASE2
NCT00105170 Safety and Tolerability of hCBE-11 in Subjects With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT00103558 Lumiliximab in Combination With FCR in Subjects With Relapsed Chronic Lymphocytic Leukemia (CLL) Status COMPLETED Phase PHASE1/PHASE2
NCT00102024 Safety and Activity of 90Y-Labeled IDEC-159 in Subjects With Metastatic Colorectal Adenocarcinoma Status TERMINATED Phase PHASE1/PHASE2
NCT00099489 Safety and Efficacy of Avonex in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Status COMPLETED Phase PHASE2
NCT00097760 Natalizumab in Combination With Glatiramer Acetate (GA) in Patients With Relapsing-Remitting Multiple Sclerosis Status COMPLETED Phase PHASE2
NCT00090051 FCR Versus FC Alone in the Treatment of Chronic Lymphocytic Leukemia (CLL) in Relapsed Patients Status COMPLETED Phase PHASE3
NCT00090038 Effect of Rituximab on Immunological Recall Response to Specific Antigens in the Treatment of Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE4
NCT00083759 Natalizumab in the Treatment of Rheumatoid Arthritis in Subjects Receiving Methotrexate Status TERMINATED Phase PHASE2
NCT00078611 A Clinical Trial of Natalizumab in Individuals With Moderately to Severely Active Crohn's Disease Status COMPLETED Phase PHASE3
NCT00057343 Safety and Efficacy of Zevalin in the Treatment of Non-Hodgkin's Lymphoma Status TERMINATED Phase PHASE3
NCT00055536 Safety and Efficacy of Natalizumab in Combination With Remicade in the Treatment of Crohn's Disease Status COMPLETED Phase PHASE2
NCT00055367 Safety, Tolerability and Effectiveness of Natalizumab in Adolescents With Active Crohn's Disease Status COMPLETED Phase PHASE2
NCT00048737 Safety and Efficacy of 90Y Zevalin in Nonmyeloablative Transplantation for Lymphoid Malignancies Status COMPLETED Phase PHASE1/PHASE2
NCT00048555 Safety and Efficacy of IDEC-114 in Combination With Rituxan in the Treatment of Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE1/PHASE2
NCT00046488 Safety and Efficacy of IDEC-152 in the Treatment of Chronic Lymphocytic Leukemia (CLL) Status COMPLETED Phase PHASE1
NCT00038623 Study Of Yttrium-ibritumomab (Zevalin) For the Treatment Of Patients With Relapsed And Refractory Mantle Cell Lymphoma Status COMPLETED Phase PHASE2
NCT00037102 Combination Therapy With Avonex and BiMonthly High Dose Intravenous Methotrexate in Multiple Sclerosis Status COMPLETED Phase PHASE4
NCT00032799 Safety and Efficacy of Natalizumab in the Treatment of Crohn's Disease Status COMPLETED Phase PHASE3